In-Depth Comparison of Fasted State Simulated Intestinal Fluid (FaSSIF) Versions via NMR Spectroscopy and Complementary Methods
- 16 July 2026
- journal article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 23 (8) , 4273-4287
Abstract
Efficient screening methods in the early drug development stage are key to quickly finding promising drug candidates. Solutions simulating conditions in the small intestine, the main absorption region for orally administered drugs, such as FaSSIF-V2 and V3, are essential. Updated versions aim to better mimic the natural environment with modified concentrations of the main components, taurocholate and lecithin, or inclusion of oxidation products. Here, we use NMR spectroscopy to investigate the aggregation behavior and interactions between drugs and/or polymers with the components in FaSSIF-V2 and -V3 on a molecular level. BCS-class II compounds carbamazepine, ketoconazole, and efavirenz served as model drugs. We found that while the individual FaSSIF versions alone showed a different apparent diffusion, addition of either drugs or polymers evened out these differences. The more complex composition of FaSSIF-V3 results in a higher signal overlap in the NMR spectra. Furthermore, the simultaneous presence of similar chemical entities with different solubilities is challenging for the DOSY analysis, as one NMR signal contains differently diffusing species. NMR spectroscopy complemented by solubility and DLS measurements as well as MD simulations showed that the different diffusion behavior of FaSSIF-V2 and -V3 is indeed a result of the solubility variations of the lecithin-like molecules. Furthermore, it was observed that all model drugs behaved differently in the FaSSIF media, spanning behavior from barely interacting (carbamazepine) to drug molecules in fast exchange between bile colloids and free solution (ketoconazole) to molecules fully incorporated into the bile aggregates (efavirenz). Although FaSSIF-V3 mimics the natural environment better, FaSSIF-V2 behaved overall more robustly across the different analytical tools and the molecular-level picture obtained for the individual media was overall similar.Keywords
Funding Information
- Fonds der Chemischen Industrie (NA)
- VINNOVA (2019-00048)
- VINNOVA (2024-03851)
- Vetenskapsrådet (2022-06725)
This publication has 56 references indexed in Scilit:
- Diffusion NMR studies of complex liquid formulationsCurrent Opinion in Colloid & Interface Science, 2020
- Diffusion in Polymer Solutions: Molecular Weight Distribution by PFG‐NMR and Relation to SECMacromolecular Chemistry and Physics, 2016
- Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: EfavirenzJournal of Pharmaceutical Sciences, 2013
- Powder Dissolution Method for Estimating Rotating Disk Intrinsic Dissolution Rates of Low Solubility DrugsPharmaceutical Research, 2009
- Postprandial Changes in Solubilizing Capacity of Human Intestinal Fluids for BCS Class II DrugsPharmaceutical Research, 2009
- Dissolution Media Simulating Conditions in the Proximal Human Gastrointestinal Tract: An UpdatePharmaceutical Research, 2008
- Estimating drug solubility in the gastrointestinal tractAdvanced Drug Delivery Reviews, 2007
- Characterization of the Human Upper Gastrointestinal Contents Under Conditions Simulating Bioavailability/Bioequivalence StudiesPharmaceutical Research, 2006
- pH-Dependent Dissolution in Vitro and Absorption in Vivo of Weakly Basic Drugs: Development of a Canine ModelPharmaceutical Research, 2005
- Comparison of a Miniaturized Shake-Flask Solubility Method with Automated Potentiometric Acid/Base Titrations and Calculated SolubilitiesJournal of Pharmaceutical Sciences, 2005